Sofosbuvir and Pancreatitis acute - a phase IV clinical study of FDA data

Summary:

Pancreatitis acute is reported as a side effect among people who take Sofosbuvir (sofosbuvir), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Daklinza, and have Hepatitis c.

The phase IV clinical study analyzes which people have Pancreatitis acute when taking Sofosbuvir. It is created by eHealthMe based on reports of 9,193 people who have side effects when taking Sofosbuvir from the FDA, and is updated regularly.

What is Sofosbuvir?

Sofosbuvir has active ingredients of sofosbuvir. eHealthMe is studying from 9,194 Sofosbuvir users. Check the latest studies of Sofosbuvir.

What is Pancreatitis acute?

Pancreatitis acute (sudden inflammation of pancreas) is found to be associated with 1,317 drugs and 1,406 conditions by eHealthMe. Check the latest studies of Pancreatitis acute.

On Jul, 16, 2026

9,193 people reported to have side effects when taking Sofosbuvir.
Among them, 32 people (0.35%) have Pancreatitis acute.

Could Sofosbuvir cause Pancreatitis acute?

Among these 32 people:

How long have people been on Sofosbuvir when they have Pancreatitis acute? *

What is the gender of people who have Pancreatitis acute when taking Sofosbuvir? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Pancreatitis acute when taking Sofosbuvir? *

What are other drugs people take besides Sofosbuvir? *

What are other side effects people have besides Pancreatitis acute? *

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 13 people, 40.62%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 13 people, 40.62%
Peritonitis Bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial): 12 people, 37.50%
Pvt: 10 people, 31.25%
Hepatic Failure (liver failure): 10 people, 31.25%
Hepatocellular Carcinoma (liver cancer): 10 people, 31.25%
Anaemia (lack of blood): 10 people, 31.25%
Erysipelas (bacterial skin infection): 9 people, 28.12%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 9 people, 28.12%
Heart Attack: 9 people, 28.12%

What are the existing conditions these people have? *

Hepatitis C: 19 people, 59.38%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 9.38%
Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 2 people, 6.25%
Oesophageal Varices Haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus): 2 people, 6.25%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 3.12%
Pancreatitis (inflammation of pancreas): 1 person, 3.12%
Indigestion: 1 person, 3.12%
Encephalopathy (functioning of the brain is affected by some agent or condition): 1 person, 3.12%
Diabetes: 1 person, 3.12%
Colitis (inflammation of colon): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Sofosbuvir and have Pancreatitis acute?

- Check whether Pancreatitis acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sofosbuvir:

Sofosbuvir (9,194 reports)

Browse all side effects of Sofosbuvir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis acute:

Pancreatitis acute (1,317 drugs)

Browse all the conditions that are associated with Pancreatitis acute:

Pancreatitis acute (1,406 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir (the active ingredients of Sofosbuvir) and Sofosbuvir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.